Alcohol Now a Leading Cause of Preventable Cancer Deaths in the US

According to researchers from the Boston University School of Medicine (BUSM) and Boston University School of Public Health (BUSPH), alcohol is a major cause of preventable cancer deaths in the United States annually. By reducing one's alcohol intake, one can effectively reduce his or her risk of developing and dying from cancer.

Said the study's lead author Timothy Naimi, MD, MPH, from the Department of Medicine at BUSM:

"The relationship between alcohol and cancer is strong, but is not widely appreciated by the public and remains underemphasized even by physicians. Alcohol is a big preventable cancer risk factor that has been hiding in plain sight."

Their findings have been published in the April issue of the American Journal of Public Health.

Alcohol linked to about 20,000 cancer deaths in the US each year

The researchers note that alcohol is a known carcinogen, regardless of how little of it is consumed, and is considered a risk factor for many cancer subtypes, including oral cancers, head and neck cancers, throat cancer, esophageal cancer, liver cancer, colon cancer, colorectal cancer, and even breast cancer.

Despite this, there has been a death of published work on just how impactful alcohol is on cancer deaths in the US. What researchers determined was that alcohol consumption could be linked to about 20,000 cancer deaths in the United States each year, or around 3.5 percent of all reported cancer deaths.

Source: MNT

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap